Last month, during a Senate hearing in which Moderna CEO Stéphane Bancel testified regarding the quadrupling in list price of the company’s Covid-19 vaccine, he cited lower consumer demand as ...
CEO Stéphane Bancel highlighted the company’s success in respiratory vaccines and outlined a focus on five non-respiratory products aiming for approvals by 2027. However, the biotech company ...
With COVID-19 revenues now shrinking fast, Moderna chief executive Stéphane Bancel has taken the decision to rein in spending and reduce the number of active development programmes, which have ...
Stéphane Bancel told CNN Business that he predicts the world will see a once-a-year vaccine in the coming years that protects against strains of COVID-19, the flu, or any other prevalent viruses ...
"Moderna now has five respiratory vaccines with positive Phase 3 results and expects to submit three for approval this year," said Moderna CEO Stéphane Bancel in a statement. "In addition ...
Fewer injections would be more convenient and simpler, Moderna says. Chief executive StephaneBancel told BBC News he hoped the messenger ribonucleic acid (mRNA) vaccine could be made widely ...
Results that may be inaccessible to you are currently showing.